Antidepressive Agents, Tricyclic

• 

  Subject Areas on Research

  • "Fibrositis" syndrome. 
  • A comparison of inpatients with primary unipolar depression and depression secondary to anxiety. 
  • A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. 
  • A controlled study of cellular immune function in affective disorders before and during somatic therapy. 
  • A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. 
  • A pilot study of mirtazapine in post-traumatic stress disorder. 
  • A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. 
  • Adding a tricyclic antidepressant to a monoamine oxidase inhibitor. 
  • Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome. 
  • Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome. 
  • Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. 
  • Antidepressant therapy in patients with ischemic heart disease. 
  • Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. 
  • Antidepressant use in elderly medical inpatients: lessons from an attempted clinical trial. 
  • Antidepressant use, depression, and survival in patients with heart failure. 
  • Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. 
  • Anxiety, depression, and heart rate variability. 
  • Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. 
  • Best clinical practice: guidelines for managing major depression in primary medical care. 
  • Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. 
  • Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. 
  • Clinical predictors of recurrence in depression. 
  • Clinical trial evidence for treatment of depression in heart failure. 
  • Concepts in pain management. 
  • Consensus statement on depression, anxiety, and cardiovascular disease. 
  • Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. 
  • Detection and treatment of major depression in older medically ill hospitalized patients. 
  • Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. 
  • Dosing recommendations and prescribing patterns for depressed medically ill hospitalized older patients. 
  • Dynamic systems theory as a paradigm for the study of change in psychotherapy: an application to cognitive therapy for depression. 
  • Dyspepsia. 
  • ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. 
  • Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. 
  • Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. 
  • Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. 
  • Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. 
  • Electrocardiogram Before Tricyclic Antidepressant Use: Minimal Impact in Pediatric Functional Gastrointestinal Disorders. 
  • Emergency department analgesia without narcotics for adults with acute sickle cell pain crisis: case reports and review of crisis management. 
  • Forms of atypical depression and their response to antidepressant drugs. 
  • Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. 
  • MAOIs in the contemporary treatment of depression. 
  • Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. 
  • Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. 
  • Neutrophil beta(2)-adrenoceptor function in major depression: G(s) coupling, effects of imipramine and relationship to treatment outcome. 
  • Paroxetine in the treatment of generalised anxiety disorder. 
  • Pharmacotherapy of generalized anxiety disorder. 
  • Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. 
  • Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome. 
  • Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. 
  • Prevention of recurrent postpartum depression: a randomized clinical trial. 
  • Prospective assessment of electroencephalographic sleep in remitted major depression. 
  • Psychopharmacologic treatment of children and adolescents with anxiety disorders. 
  • Review of the use of mirtazapine in the treatment of depression. 
  • Sensory neuromodulators in functional nausea and vomiting: predictors of response. 
  • Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. 
  • Should physicians screen for depression in elderly medical inpatients?: Results of a decision analysis. 
  • The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. 
  • The long-term treatment of panic disorder. 
  • The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. 
  • The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. 
  • The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. 
  • The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. 
  • Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata. 
  • Toward a rational pharmacotherapy of depression. 
  • Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. 
  • Treatment considerations for patients with neuropathic pain and other medical comorbidities. 
  • Tricyclic antidepressant prescribing for nonpsychiatric disorders. An analysis based on data from the 1985 National Ambulatory Medical Care Survey. 
  • Tricyclic antidepressants. 
  • Tricyclic-induced akathisia in patients taking conjugated estrogens. 
  • Vintage treatments for PTSD: a reconsideration of tricyclic drugs. 
• 

  Keywords of People

  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology